From January 1, 2024 to January 11, 2024, the company has repurchased 1,049,800 shares, representing 0.22% for CNY 60 million. With this, the company has completed the repurchase of 1,696,800 shares, representing 0.36% for CNY 99.99 million under the buyback announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.61 CNY | -3.04% | +3.29% | -36.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.69% | 2.55B | |
-17.08% | 8.39B | |
+45.61% | 3.74B | |
-9.28% | 2.48B | |
-13.43% | 2.32B | |
-6.49% | 1.93B | |
-17.24% | 1.6B | |
-37.21% | 1.28B | |
+5.14% | 1.08B | |
-17.22% | 871M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.